In this study, the serum levels of CysC, IMA, and LP-PLA2 in patients with T2DM with LEASOD were measured, and the correlation with the severity of the disease was analyzed to make an effective assessment of the degree of lesions in these patients with this index and to provide the basis for clinical diagnosis and treatment. The gene discussed is PLA2G7; the disease is type 2 diabetes mellitus.